comparemela.com

Latest Breaking News On - John fahy - Page 10 : comparemela.com

Aer Therapeutics Closes $36 Million Series A Funding Round to Advance Development of an Innovative Mucolytic for the Treatment of Lung Diseases

Aer Therapeutics, a joint University College Dublin and University of California, San Francisco biopharmaceutical spin-out company developing novel in..

North carolinaUnited statesSan franciscoJohn fahyJim shafferTim shannonChristy shafferAnne marie healyThomas mathersStefan oscarsonUniversity of californiaNational institutes of healthSchool of chemistryTrinity college dublinUniversity college dublinAer therapeutics

Aer Therapeutics bags €32 7M to develop treatment for mucus-associated lung diseases: Know more

Aer Therapeutics, a biopharmaceutical spin-out company has secured $36M (approximately €32.7M) in a Series A round of funding.

United statesSan franciscoChristy shafferAnne marie healyJohn fahyThomas mathersStefan oscarsonTim shannonJim shafferTrinity college dublinUniversity of californiaSchool of chemistryBlood instituteUniversity college dublinNational institutes of healthNational institutes of health heart lung

UCD spin-out raises €32 5m to develop pulmonary disease drug

Aer Therapeutics receives money from a syndicate of premier life science industry investors

North carolinaUnited statesSan franciscoStefan oscarsonJim shafferAnne marie healyJohn fahyUniversity of californiaTrinity college dublinSchool of chemistryAer therapeuticsHatteras ventureProf john fahyProf stefan oscarsonProf oscarsonProf anne marie healy

Aer Therapeutics Raises $36M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesSan franciscoStefan oscarsonThomas mathersJim shafferChristy shafferJohn fahyTim shannonUniversity college dublinUniversity of californiaAer therapeuticsNorth carolina basedHatteras ventureHatteras venture partnersProfessor john fahyProfessor stefan oscarson

Aer Therapeutics Closes $36 Million Series A to Advance Development of AER-01, an Innovative Mucolytic for the Treatment of Lung Diseases

/PRNewswire/ Aer Therapeutics, a biopharmaceutical company developing novel inhaled treatments for muco-obstructive lung diseases, today announced the.

San franciscoUnited statesThomas mathersTim shannonJim shafferJohn fahyAnne marie healyStefan oscarsonChristy shafferBlood instituteUniversity of californiaTrinity college dublinUniversity college dublinNational institutes of healthNational institutes of health heart lungHatteras venture

vimarsana © 2020. All Rights Reserved.